Results 271 to 280 of about 2,872,365 (306)

The duration dilemma in opioid agonist therapy.

Journal of Opioid Management, 2021
OBJECTIVE Studies dating back to 1964 consistently support the effectiveness of methadone as a maintenance treatment for opioid use disorder (OUD), and since 2003, the effectiveness of buprenorphine.
A. Dhanda, E. Salsitz
semanticscholar   +3 more sources

Relationship between choice of opioid agonist therapy and distance from patients’ residences in Taiwan, 2012–2014

American Journal of Drug and Alcohol Abuse, 2021
Background Choice of opioid agonist therapy (OAT) for opioid use disorder (OUD) can be impacted by variables such as age, sex, and socioeconomic status.
Hung-Yu Chan, Lien-Chung Wei
exaly   +2 more sources

Barriers to accessing opioid agonist therapy in pregnancy.

American Journal of Obstetrics & Gynecology MFM, 2020
BACKGROUND The incidence of opioid use disorder during pregnancy has risen dramatically in the last couple of decades. Despite the safety and efficacy of treatment for opioid use during pregnancy, pregnant women often cannot access treatment ...
Bronwyn S. Bedrick, Carly M. O’Donnell, C. Marx, H. Friedman, E. Carter, M. Stout, J. Kelly   +6 more
semanticscholar   +3 more sources

Utilization of Opioid Agonist Therapies in Canada

Canadian Journal of Health Technologies, 2023
Canada continues to experience an opioid crisis that has had a devastating impact on public health, highlighting the importance of management strategies for opioid use disorder (OUD). Several opioid agonist therapies (OATs) for the management of OUD are available in Canada, including recent approvals of new brand name drugs and generic versions of ...
Ari Mendell, Chris Vannabouathong, Kim Le, Peter Dyrda   +3 more
openaire   +1 more source

OPIOID AGONIST THERAPY SWITCHING AMONG INDIVIDUALS WITH PRESCRIPTION-TYPE OPIOID USE DISORDER: SECONDARY ANALYSIS OF A PRAGMATIC RANDOMIZED TRIAL

Drug and Alcohol Dependence, 2023
Background Engagement and retention in opioid agonist therapy (OAT) remains a challenge. This study evaluated the impact of initial randomized OAT allocation on subsequent switching among people with prescription-type opioid use disorder (POUD).
Victor Mocanu, N. Bozinoff, Evan Wood, Didier Jutras-Aswad, B. Le Foll, Ronald Lim, Jin Cheol Choi, Wing-Yin Mok, M. Socías   +8 more
semanticscholar   +1 more source

Association of opioid agonist therapy with the initiation of antiretroviral therapy - a systematic review [PDF]

International Journal of Infectious Diseases, 2016
People who inject drugs are at high risk of HIV infection but often face barriers in accessing medical care including access to antiretroviral therapy (ART). Evidence is available about the effectiveness of opioid agonist therapy on drug dependency and risk behaviors.
Junko Yasuoka, Bruno F Sunguya
exaly   +3 more sources

Reinfection and Risk Behaviors After Treatment of Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy

Annals of Internal Medicine, 2022
BACKGROUND Hepatitis C virus (HCV) reinfection after successful treatment may reduce the benefits of cure among people who inject drugs. OBJECTIVE To evaluate the rate of HCV reinfection for 3 years after successful treatment among people receiving ...
J. Grebely, G. Dore, F. Altice, B. Conway, A. Litwin, B. Norton, O. Dalgard, E. Gane, O. Shibolet, R. Nahass, A. Luetkemeyer, C. Peng, D. Iser, I. Gendrano, M. Kelly, P. Hwang, E. Asante-Appiah, B. Haber, E. Barr, M. Robertson, H. Platt   +20 more
semanticscholar   +1 more source

Punitive discontinuation of opioid agonist therapy during incarceration

International Journal of Prisoner Health, 2020
Purpose The prevalence of substance use disorders among incarcerated individuals in Canada is substantially higher than in the general population. Many incarcerated individuals with opioid use disorder remain untreated due to inadequate access to opioid agonist therapy (OAT).
Allison, Marmel, Nikki, Bozinoff
openaire   +2 more sources

When will opioid agonist therapy become a normal part of comprehensive health care?

Medical Journal of Australia, 2021
Rates of prescribing, morbidity and mortality have dramatically increased since 1990.1 Fiftysix percent of unintentional opioid deaths now involve pharmaceutical opioids (as either sole drug or polydrug overdose), compared with 45% of deaths involving ...
Pallavi Prathivadi, E. Sturgiss
semanticscholar   +1 more source

Chronic pain, craving, and illicit opioid use among patients receiving opioid agonist therapy [PDF]

Drug and Alcohol Dependence, 2016
In a sample of patients receiving opioid agonist therapy, we evaluated whether having chronic pain was associated with (a) craving for opioids and (b) illicit opioid use.In a cross-sectional study of adults on buprenorphine or methadone maintenance recruited from an urban medical center, we examined any craving for opioids (primary dependent variable ...
Marlene C Lira, Debbie M Cheng
exaly   +3 more sources